Netherlands

Netherlands Severe Asthma Index

Rank

(out of 24 countries)

11

Index Score

(out of 100)

65.89

Deaths

(as a % of overall deaths)

8.9%

Smoking Rate

5.7%

Above average performance

Average performance

Below average performance

Overview

The Netherlands reports an average score in the Policy Context category, in part due to the existence of a national asthma strategy and severe asthma guidelines. However, limited alignment of national guidelines with international best practices and tobacco control laws lowers the Netherlands’ score. In terms of Access and Care Coverage, the Netherlands scores second compared to all other countries. This is due to excellent access to treatment (including biologics), diagnostics, and telemedicine – though the Netherlands could improve access to specialist care and digital therapeutics. Notably, the Netherlands ranks among the lowest in terms of Disease Burden score. This is attributable to a high estimated societal cost of severe asthma and DALYs attributable to asthma, as well as adult tobacco use and obesity rates slightly higher than the average.

How does Netherlands perform in each category?

Provides further insights into how Netherlands scores across each Index category

Netherlands takeaways

Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Netherlands

Insight_6.webp

The Netherlands has a strong asthma strategy and severe asthma guidelines as well as contributing data to a severe asthma registry

Insight_34.webp

The Netherlands has the second highest score in Access and Care Coverage, though limited access to specialist care

Insight_33.webp

The Netherlands has a low score in Disease Burden with high societal cost and DALYs attributable to asthma

Compare Netherlands to other countries

Select different countries to see how they scored across each of the 5 categories and overall